CONTACT US
Home > Inhibitors/Agonists> > l-Lysergide
3184-49-4-l-Lysergide l-Lysergide

l-Lysergide

For research use only. Not for therapeutic Use.

  • CAT Number: I030908
  • CAS Number: 3184-49-4
  • Molecular Formula: C20H25N3O
  • Molecular Weight: 323.44
  • Purity: 98%
Inquiry Now
Related Small Molecules: Imalumab     MLT-747     tert-Butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate    

l-Lysergide is discontinued (DEA controlled substance). l-Lysergide is a psychedelic drug.


Catalog Number I030908
CAS Number 3184-49-4
Synonyms

l-Lysergide; l-LSD; (-)-Lysergic acid diethylamide;

Molecular Formula C20H25N3O
Purity 98%
Solubility Soluble in DMSO
Appearance Solid powder
Storage Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
IUPAC Name (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
InChI InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1
InChIKey VAYOSLLFUXYJDT-RDTXWAMCSA-N
SMILES [H][C@@]1(N(C[C@@H](C=C12)C(N(CC)CC)=O)C)CC3=CNC4=C3C2=CC=C4
Reference

1: Himmelsbach M, Ferdig M, Rohrer T. Analysis of paspalic acid, lysergic acid, and iso-lysergic acid by capillary zone electrophoresis with UV- and quadrupole time-of-flight mass spectrometric detection. Electrophoresis. 2014 May;35(9):1329-33. doi: 10.1002/elps.201300224. Epub 2013 Oct 18. PubMed PMID: 24115177.
2: Merli D, Zamboni D, Protti S, Pesavento M, Profumo A. Electrochemistry and analytical determination of lysergic acid diethylamide (LSD) via adsorptive stripping voltammetry. Talanta. 2014 Dec;130:456-61. doi: 10.1016/j.talanta.2014.07.037. Epub 2014 Jul 22. PubMed PMID: 25159435.
3: GIBERTI F, GREGORETTI. [Comparative study of the psychopathological effects of lysergic acid ethylamide, (L. A. E. 32) & lysergic acid diethylamide, (L. S. D. 25) in neurotics]. Sist Nerv. 1958 Mar-Apr;10(2):97-110. Italian. PubMed PMID: 13580425.
4: Sarsúnová M, Semonský M, Cerný A. Ergot alkaloids. XXXVI. Separation of diastereomeric (+)-1-hydroxy-2-butylamides of D- and L-lysergic and D- and L-isolysergic acids by thin-layer chromatography. J Chromatogr. 1970 Aug 12;50(3):442-6. PubMed PMID: 5449459.
5: HOFMANN A, TSCHERTER H. [Isolation of lysergic acid alkaloids from the Mexican drug ololiuqui (Rivea corymbosa (L.) Hall.f.)]. Experientia. 1960 Sep 15;16:414. German. PubMed PMID: 13715089.
6: Inuki S, Iwata A, Oishi S, Fujii N, Ohno H. Enantioselective total synthesis of (+)-lysergic acid, (+)-lysergol, and (+)-isolysergol by palladium-catalyzed domino cyclization of allenes bearing amino and bromoindolyl groups. J Org Chem. 2011 Apr 1;76(7):2072-83. doi: 10.1021/jo102388e. Epub 2011 Mar 1. PubMed PMID: 21361331.
7: Keller U, Han M, Stöffler-Meilicke M. D-lysergic acid activation and cell-free synthesis of D-lysergyl peptides in enzyme fractions from the ergot fungus Claviceps purpurea. Biochemistry. 1988 Aug 9;27(16):6164-70. PubMed PMID: 2847788.
8: Sietnieks A. Involvement of 5-HT2 receptors in the LSD- and L-5-HTP-induced suppression of lordotic behavior in the female rat. J Neural Transm. 1985;61(1-2):65-80. PubMed PMID: 3872342.
9: Winkelhake JL, Voss EW Jr, Lopatin DE. Comparative inhibitory action of D- and L-tryptophan on the effect of d-lysergic acid diethylamide in vitro. Mol Pharmacol. 1974 Jan;10(1):68-77. PubMed PMID: 4136154.
10: Truhaut R, Deysson G. [Absence of lysergic diethylamide effect on the chromosomes in Allium sativum L. meristematic radicular cells]. C R Acad Sci Hebd Seances Acad Sci D. 1970 Feb 23;270(8):1165-6. French. PubMed PMID: 4985239.
11: Mendoza A, López de Alda M, González-Alonso S, Mastroianni N, Barceló D, Valcárcel Y. Occurrence of drugs of abuse and benzodiazepines in river waters from the Madrid Region (Central Spain). Chemosphere. 2014 Jan;95:247-55. doi: 10.1016/j.chemosphere.2013.08.085. Epub 2013 Sep 29. PubMed PMID: 24083902.
12: Sietnieks A, Meyerson BJ. Progesterone enhancement of lysergic acid diethylamide and levo-5-hydroxytryptophan stimulation of the copulatory response in the female rat. Neuroendocrinology. 1983 Jun;36(6):462-7. PubMed PMID: 6603590.
13: Yamamoto T, Walker EA, Woods JH. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan. J Pharmacol Exp Ther. 1991 Sep;258(3):999-1007. PubMed PMID: 1890629.
14: Hungen KV, Roberts S, Hill DF. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain. Brain Res. 1975 Aug 22;94(1):57-66. PubMed PMID: 238721.
15: Nichols DE. Hallucinogens. Pharmacol Ther. 2004 Feb;101(2):131-81. Review. PubMed PMID: 14761703.
16: Kerrigan S, Brooks DE. Indirect enzyme-linked immunosorbent assay for the quantitative estimation of lysergic acid diethylamide in urine. Clin Chem. 1998 May;44(5):985-90. PubMed PMID: 9590371.
17: Abraham HD. L-5-hydroxytryptophan for LSD-induced psychosis. Am J Psychiatry. 1983 Apr;140(4):456-8. PubMed PMID: 6601463.
18: Filla A, Hiripi L, Elekes K. Serotonergic and dopaminergic influence of the duration of embryogenesis and intracapsular locomotion of Lymnaea stagnalis L. Acta Biol Hung. 2004;55(1-4):315-21. PubMed PMID: 15270248.
19: Chiu S, Mishra RK. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy. Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(1):45-50. PubMed PMID: 6111027.
20: Klinke HB, Müller IB, Steffenrud S, Dahl-Sørensen R. Two cases of lysergamide intoxication by ingestion of seeds from Hawaiian Baby Woodrose. Forensic Sci Int. 2010 Apr 15;197(1-3):e1-5. doi: 10.1016/j.forsciint.2009.11.017. Epub 2009 Dec 16. PubMed PMID: 20018470.

Request a Quote